质瘤中的生物氨基:全面的文献综述
Ahmad Abuaisheh1, Orwa Aboud2,3,4
1School of Medicine, Al Balqa Applied University, 19117 Al Balqa, Jordan.
Frontiers in bioscience (Landmark edition)
|August 1, 2023
概括
生物氨基胺,即氨基酸中的有机化合物,可能在质瘤的发展和治疗中发挥作用. 需要进一步的研究来探索它们对脑瘤的全部影响.
科学领域:
- 神经瘤学神经瘤学
- 生物化学 生物化学
- 瘤发生的起源
背景情况:
- 质瘤是最常见的原发性脑瘤,起源于神经质细胞.
- 尽管进行了广泛的研究,但高度质瘤的预后不佳.
- 来自氨基酸的生物氨基,已知有毒性和致癌性.
研究的目的:
- 研究生物氨基胺在质瘤发育中的作用.
- 探索生物胺在质瘤中的诊断潜力.
- 检查生物氨基胺在质瘤治疗中的未来治疗应用.
主要方法:
- 对生物源性胺和质瘤现有研究的文献综述.
- 分析涉及癌症中的生物氨基胺的生化途径.
- 综合当前关于生物氨酸参与中枢神经系统 (CNS) 瘤的知识.
主要成果:
- 生物氨基因涉及到各种癌症的发病.
- 特定的生物氨基可能作为潜在的生物标志物用于质瘤诊断.
- 调节生物氨基水平可能会提供新的治疗策略.
结论:
- 生物氨基胺代表着质瘤研究的一个有前途的领域.
- 了解生物氨基的功能可以促进质瘤的诊断和治疗.
- 需要进一步的研究,以充分阐明生物胺在质瘤中的作用.
相关概念视频
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...


